All In Biotech

Drug Trial Radar · NCT02750514

An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

A Phase 2, Fast Real Time Assessment of Combination Therapies in Immuno-Oncology Study in Subjects With Advanced Non-Small Cell Lung Cancer (FRACTION-Lung)

Last checked: Nov 19, 2026Latest source record: Mar 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 295 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

295

Actual

Start

May 9, 2016

Primary completion

Jan 29, 2020

Study completion Jan 29, 2020

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Apr 25, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether Nivolumab, in combination with other therapies, is effective in patients with advanced Non-Small Cell lung cancer

Conditions

  • Advanced Cancer

Interventions

  • NivolumabBiological

    Arm associated with this intervention is closed. Nivolumab is no longer given as an active comparator.

  • DasatinibDrug

  • RelatlimabBiological

  • IpilimumabBiological

  • BMS-986205Drug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR)Time frame: From first dose to 2 years following last dose (up to 30 months)
  2. Duration of Response (DOR)Time frame: From first dose to 2 years following last dose (up to 30 months)
  3. Progression Free Survival Rate (PFSR) at 24 WeeksTime frame: From first dose to 24 weeks after first dose

Locations

50 sites in 8 countries. Site status is shown where the registry gives one.

  • City of Hope National Medical Center

    Duarte, California

  • University of Southern California (USC)

    Los Angeles, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • University of Californa, Los Angeles (UCLA)

    Los Angeles, California

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

  • University of California San Diego

    San Diego, California

  • University of Colorado Denver

    Aurora, Colorado

  • Yale Cancer Center

    New Haven, Connecticut

  • University of Kansas Cancer Center

    Westwood, Kansas

  • University of Maryland - Marlene and Stewart Greenebaum Cancer Center

    Baltimore, Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Dana Farber/Harvard Cancer Center

    Boston, Massachusetts

  • University of Michigan Health System (UMHS) - University Hospital (University of Michigan Medical Ce

    Ann Arbor, Michigan

  • Karmanos Cancer Institute

    Detroit, Michigan

  • Washington University, The Center for Advanced Medicine

    St Louis, Missouri

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada

  • Roswell Park Cancer Institute

    Buffalo, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Univ of NC Shool of Medicine

    Chapel Hill, North Carolina

  • The Ohio State University

    Columbus, Ohio

  • Northwest Cancer Specialists

    Portland, Oregon

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • The West Clinic, P.C. d/b/a West Cancer Center

    Germantown, Tennessee

  • Sarah Cannon Cancer Center

    Nashville, Tennessee

  • Sammons Cancer Center (Uso)

    Dallas, Texas

  • Texas Oncology, P.A.

    Fort Worth, Texas

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas

  • Us Oncology

    Tyler, Texas

  • Huntsman Cancer Institute

    Salt Lake City, Utah

  • Virginia Cancer Specialists, PC

    Fairfax, Virginia

  • University of Washington-Seattle Cancer Care Alliance

    Seattle, Washington

  • Local Institution

    Clayton, Victoria, Australia

  • Local Institution

    Salzburg, Austria

  • Local Institution

    Edmonton, Canada

  • Juravinski Cancer Centre, Hamilton Health Sciences-Mcmaster Univeristy's Faculty Of Health Sciences

    Hamilton, Ontario, Canada

  • University Of Ottawa - The Ottawa Hospital Cancer centre

    Ottawa, Ontario, Canada

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.